Oligodendrocyte (OLG) damage leads to demyelination, which is frequently observed in ischemic cerebrovascular diseases. In this study, we investigated the effect of bone marrow stromal cells (BMSCs) on OLGs subjected to oxygen-glucose deprivation (OGD). N20.1 cells (mouse OLG cell line) were transferred into an anaerobic chamber for 3 hr in glucose-free and serum-free medium. After OGD incubation, OLG cultures were divided into the following groups: 1) OGD alone, 2) OLG cocultured with BMSCs, 3) treatment with the phosphoinostide 3-kinase (PI3k) inhibitor LY294002, 4) LY294002-treated OLGs with BMSC cocultured, and 5) anti-p75 antibody-treated OLGs. After an additional 3 hr of reoxygenation incubation, OLG viability and apoptosis were measured. The mRNA expression in the BMSCs and OLGs was analyzed using quantitative real-time PCR (RT-PCR). Serine/threonine-specific protein kinase (Akt), phosphorylated Akt (p-Akt), p75, and caspase 3 protein expressions in OLGs were measured by Western blot. Our results suggest that BMSCs produce growth factors, activate the Akt pathway, and increase the survival of OLGs. BMSCs also reduce p75 and caspase 3 expressions in the OGD-OLGs, which leads to decreased OLG apoptosis. BMSCs participate in OLG protection that may occur with promoting growth factors/PI3K/Akt and inhibiting the p75/caspase pathways. Our study provides insight into white matter damage and the therapeutic benefits of BMSC-based remyelinating therapy after stroke and demyelinating diseases.
Keywordsbone marrow stromal cells; oligodendrocytes; oxygen-glucose deprivation Oligodendrocytes (OLGs) generate the myelin sheaths that enwrap axons and thus play a pivotal role in the proper execution of neural function (Shibata et al., 2000). OLGs are very vulnerable to hypoxic and ischemic insults (Lyons and Kettenmann, 1998;Pantoni et al., 1996); damage to them leads to demyelination, which is frequently observed in ischemic cerebrovascular diseases and contributes to neurological functional impairment (Shibata et al., 2000;Li et al., 2005Li et al., , 2006Gresle et al., 2006). The precise mechanisms underlying the ischemia-induced death of OLGs are currently unknown (Shibata et al., 2000). Many factors determine the vulnerability of OLGs after ischemia (Dirnagl et al., 1999), such as caspases (Shibata et al., 2000), excitotoxicity (Matute et al., 2007), and oxidative stress (Imai et al., 2001). Therapeutic interventions are needed to protect OLGs as well as neurons and thereby to reduce neurological deficits after stroke. Our previous studies found that bone marrow Li et al., 2002;Zhang et al., 2004) and protected neural cells (i.e., neurons, astrocytes) from ischemic injury (Li et al., 2000Chopp and Li, 2002;Gao et al., 2005). However, the effect of BMSCs on ischemic OLGs has not been investigated.Growth factors bind to the tyrosine kinase receptors of neural cells, induce the production of phosphatidylinositol 3,4,5 [PtdIns(3,4,5)P3] by phosphoinostide 3-kinase (PI3K; Vlahos et al., 1994), activate the Akt ca...